(AKE) Arkema - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010313833
AKE EPS (Earnings per Share)
AKE Revenue
AKE: Adhesives, Polymers, Coatings, Additives, Chemicals
Arkema SA is a global specialty chemicals company operating in three distinct segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The company provides a wide range of innovative materials and solutions that cater to various industries, including construction, automotive, electronics, and energy. With a presence in over 50 countries, Arkema has established itself as a leading player in the global chemicals market.
The Adhesive Solutions segment is a key contributor to Arkemas revenue, offering a diverse portfolio of products that include sealants, adhesives, and waterproofing systems. The segments focus on innovation and customer-centricity has enabled Arkema to maintain a strong market position. Additionally, the companys performance polymers and additives business provides a range of high-performance materials used in various industrial applications.
The Advanced Materials and Coating Solutions segment is another significant revenue driver for Arkema, offering a range of coating solutions, additives, and specialties that cater to various industries, including decorative paints, industrial coatings, and adhesives. The segments focus on innovation and sustainability has enabled Arkema to stay ahead of the competition.
From a technical analysis perspective, Arkemas stock price has been trending downwards, with the SMA20 and SMA50 indicators suggesting a bearish trend. The stock is currently trading below its 200-day moving average, indicating a potential long-term downtrend. However, the ATR indicator suggests that the stocks volatility is relatively low, which could be a positive sign for investors.
Using the available
Based on the available data, our forecast is that Arkemas stock price will trade between 55 and 65 in the next 6 months, with a potential bias towards the lower end of this range. However, investors should closely monitor the companys fundamental performance and technical indicators for any signs of a turnaround.
Additional Sources for AKE Stock
AKE Stock Overview
Market Cap in USD | 5,261m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Diversified Chemicals |
IPO / Inception |
AKE Stock Ratings
Growth Rating | -31.8 |
Fundamental | 3.39 |
Dividend Rating | 75.4 |
Rel. Strength | -23.2 |
Analysts | - |
Fair Price Momentum | 55.96 EUR |
Fair Price DCF | 58.17 EUR |
AKE Dividends
Dividend Yield 12m | 5.34% |
Yield on Cost 5y | 5.08% |
Annual Growth 5y | 9.73% |
Payout Consistency | 97.2% |
Payout Ratio | 91.4% |
AKE Growth Ratios
Growth Correlation 3m | -14.8% |
Growth Correlation 12m | -74.7% |
Growth Correlation 5y | -31% |
CAGR 5y | -2.78% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | -0.62 |
Alpha | -29.65 |
Beta | 0.589 |
Volatility | 27.80% |
Current Volume | 203.6k |
Average Volume 20d | 195.5k |
As of June 26, 2025, the stock is trading at EUR 61.40 with a total of 203,551 shares traded.
Over the past week, the price has changed by +2.93%, over one month by -3.91%, over three months by -14.27% and over the past year by -23.33%.
Neither. Based on ValueRay´s Fundamental Analyses, Arkema is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.39 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AKE is around 55.96 EUR . This means that AKE is currently overvalued and has a potential downside of -8.86%.
Arkema has no consensus analysts rating.
According to our own proprietary Forecast Model, AKE Arkema will be worth about 62.8 in June 2026. The stock is currently trading at 61.40. This means that the stock has a potential upside of +2.25%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 86.4 | 40.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 62.8 | 2.2% |